-
-
-
-
-
-
-
Barclays Downgrades Pacific Biosciences of California (PACB) to Underweight
-
-
-
-
-
-
-
PacBio and UC Davis develop CiFi sequencing method for genome assembly
-
-
-
-
-
-
-
PACB expands PureTarget portfolio for carrier screening market
-
-
-
-
-
-
-
Pacific Biosciences of California (PACB) PT Lowered to $3 at Jefferies
-
-
-
-
-
-
-
Pacific Biosciences of California (PACB) PT Lowered to $2 at Scotiabank
-
-
-
-
-
-
-
Pacific Bio (PACB) names David Ruggiero as new Global Head of Sales
-
-
-
-
-
-
-
Pacific Bio (PACB) Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing
-
408,185 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

